ASSESSMENT OF VARIANCE IN BIOAVAILABILITY STUDIES - COMMENT

被引：4

作者：

METZLER, CM

机构：

来源：

PHARMACEUTICAL RESEARCH | 1987年 / 4卷 / 06期

关键词：

D O I：

10.1023/A:1016448110088

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：536 / 536

页数：1

相关论文

共 5 条

[1] ASSESSMENT OF 75/75 RULE - FDA VIEWPOINT
CABANA, BE
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (01) : 98 - 99
[2] FLUEHLER H, 1981, J PHARMACOKINET BIOP, V9, P235
[3] FDA 75/75 RULE - A RESPONSE
HAYNES, JD
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (01) : 99 - 100
[4] STATISTICAL SIMULATION STUDY OF NEW PROPOSED UNIFORMITY REQUIREMENT FOR BIOEQUIVALENCY STUDIES
HAYNES, JD
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (06) : 673 - 675
[5] INFLUENCE OF TABLET DISSOLUTION ON FUROSEMIDE BIOAVAILABILITY - A BIOEQUIVALENCE STUDY
MCNAMARA, PJ
FOSTER, TS
DIGENIS, GA
PATEL, RB
CRAIG, WA
WELLING, PG
RAPAKA, RS
PRASAD, VK
SHAH, VP
[J]. PHARMACEUTICAL RESEARCH, 1987, 4 (02) : 150 - 153